Article

Results of a worldwide External Quality Assessment of cfDNA testing in Lung Cancer

2022-05-12

Abstract excerpt

<h4>Background: </h4> Circulating cell free DNA (cfDNA) testing of plasma for EGFR somatic variants in lung cancer patients is being widely implemented and with any new service, external quality assessment (EQA) is required to ensure patient safety. An international consortium, International Quality Network for Pathology (IQNPath), has delivered a second round of assessment to measure the accuracy of cfDNA testing...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3105a3b3-50c5-5ed0-a786-a7616fd5d8fe
DOI: 10.21203/rs.3.rs-1459203/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Results of a worldwide External Quality Assessment of cfDNA testing in Lung CancerDOI 10.21203/rs.3.rs-1459203/v1Read

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.Semantic proximity Read

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.Semantic proximity Read

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.Semantic proximity Read

Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.Semantic proximity Read

Clinical Testing for Tumor Cell-Free DNA: College of American Pathologists Proficiency Programs Reveal Practice Trends.Semantic proximity Read

External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.Semantic proximity Read

Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA.Semantic proximity Read

Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey.Semantic proximity Read

External quality assessment for EGFR mutations in Italy: improvements in performances over the timeSemantic proximity Read

What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases.Semantic proximity Read

A Comparative Study for Detection of EGFR Mutations in Plasma Cell-Free DNA in Korean Clinical Diagnostic Laboratories.Semantic proximity Read

Results of the UK NEQAS for Molecular Genetics reference sample analysis.Semantic proximity Read